Publications by authors named "N P Maillard"
Article Synopsis
- Apheresis is a medical procedure used to quickly remove harmful antibodies in diseases like anti-GBM and severe ANCA-associated vasculitis, and the CINEVAS study compared two methods: immunoadsorption (IA) and plasma exchange (PEx).
- The study analyzed results from 38 patients and found that both IA and PEx effectively reduced autoantibody levels similarly, with 98% reduction for IA and 96% for PEx after seven sessions.
- While IA showed a greater reduction in total IgG and better preservation of IgA and IgM, the volume of plasma used and session lengths differed between the techniques, but overall, their effectiveness in removing antibodies was comparable.
Background And Hypothesis: Recurrence of focal segmental glomerulosclerosis (FSGS) is common after kidney transplantation and is classically associated with a significant decrease in graft survival. A major risk factor is a prior history of FSGS recurrence on a previous graft. This analysis reports the impact of a prophylactic treatment of FSGS recurrence in very high-risk patients who experienced a recurrence on a previous graft.
View Article and Find Full Text PDFIDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantation.
Hemasphere
March 2024
Introduction: IgA nephropathy's (IgAN's) MEST-C classification relationship with complement activation is still not fully understood because of limited and conflicting evidence. Our study aimed to delineate this relationship through a systematic review.
Methods: We adhered to the Preferred Reporting Items for Systematic Review and Meta-analysis guidelines and conducted a systematic review, utilizing databases like MEDLINE (PubMed), Embase, Scopus, and Cochrane from January 2016 (year of updated MEST-C classification) to January 2023.
The use of peripheral blood (PB) or bone marrow (BM) stem cells graft in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide (PTCy) for graft-versus-host disease (GVHD) prophylaxis remains controversial. Moreover, the value of adding anti-thymoglobulin (ATG) to PTCy is unknown. A total of 1344 adult patients received an unmanipulated haploidentical transplant at 37 centers from 2012 to 2019 for hematologic malignancy.
View Article and Find Full Text PDF